AUS
NZ
UK
CA
USA
IND
Healt
CSL Share Update: Key Insights Ahead of February Results
January 22, 2026 05:43 PM AEDT| By SamCSL Ltd (CSL.AX) gains on ASX rally as investors await February half-year results, focusing on plasma collection, vaccine demand, and sector trends.
Osteopore’s Hong Kong Entry Signals New Chapter in Asia Growth
January 22, 2026 04:03 PM AEDT| By SamExplore how Osteopore’s Hong Kong expansion strengthens its Asia footprint, supports advanced orthopaedic care, and connects with broader trends shaping the regional medical device and ASX stock market landscape.
ASX 200 Watch: 4DMedical Strengthens Market Position
January 22, 2026 02:53 PM AEDT| By Sam4DMedical’s latest market update highlights steady capital management, reinforcing its role within Australia’s evolving healthcare and technology landscape while supporting broader market stability.
ASX 200 Spotlight: Sonic Healthcare’s Valuation Story Unfolds
January 22, 2026 12:20 PM AEDT| By SamSonic Healthcare remains a key ASX 200 healthcare name, with valuation discussions now shaped by earnings quality, cash flow strength, and its long-term role in the sector.
Proteomics International Activity Within ASX 200 Today Healthcare Framework
January 21, 2026 04:52 PM AEDT| By SamProteomics International has released an ASX update on the quotation of newly issued shares, reflecting standard disclosure practices within Australia’s healthcare and biotechnology sector.
Healthcare Innovation Spotlight as LTR Pharma Engages ASX 300 Framework
January 21, 2026 04:25 PM AEDT| By SamLTR Pharma released a healthcare sector update outlining an exchange-related step tied to issued capital, aligning with standard disclosure practices across Australian market indices.
Adheris Health (ASX:AHE) Shares Track All Ordinaries Index
January 21, 2026 04:21 PM AEDT| By SamA factual review of Adheris Health Limited covering sector placement, digital healthcare services, and broader market context referenced through the All Ordinaries.
Mesoblast Advances Regenerative Medicine Operations Within ASX 200 Market Structure
January 21, 2026 04:17 PM AEDT| By SamMesoblast operates within the biotechnology sector, advancing regenerative cellular therapies while maintaining representation within the ASX 200 and ASX 300 indices.
Telix Pharmaceuticals Operates Within Biotechnology Sector Under ASX 200 Market Framework
January 21, 2026 02:51 PM AEDT| By SamTelix Pharmaceuticals operates within the biotechnology sector, delivering radiopharmaceutical innovation while maintaining inclusion within the ASX 200, ASX 300, and All Ordinaries indices.
ASX 200 Spotlight: 4DMedical Expands Market Presence With New Share Quotation
January 21, 2026 11:40 AM AEDT| By Sam4DMedical strengthens its ASX presence through a new share quotation, reinforcing momentum in Australia’s healthcare technology sector and reflecting broader market evolution.
Anteris Technologies Strengthens Healthcare Position Across All Ordinaries Landscape
January 21, 2026 11:08 AM AEDT| By SamAnteris Technologies operates within the healthcare technology sector, delivering medical device innovation while maintaining representation within the All Ordinaries index.
Adheris Health Strengthens Digital Care Delivery Role Within All Ordinaries Healthcare Segment
January 21, 2026 10:49 AM AEDT| By SamAdheris Health delivers digital patient adherence and engagement services, reinforcing its role within the All Ordinaries healthcare technology segment.
Ansell Performance Insights Within the ASX 100 Landscape
January 20, 2026 06:20 PM AEDT| By SamObjective review of Ansell (ASX:ANN) highlights revenue stability, EPS decline, and dividend contributions, providing factual insights within the ASX 100 sector context.
ASX 50: Sonic Healthcare (ASX:SHL) Maintains Dividend Program
January 20, 2026 05:11 PM AEDT| By SamObjective review of Sonic Healthcare (ASX:SHL), detailing diagnostics operations, European expansion, dividend consistency, and market positioning within ASX 50 top companies.
Australia Stocks Close Lower as S&P/ASX 200 Reflects Broad ASX Market Movement
January 20, 2026 05:07 PM AEDT| By SamAustralian shares ended lower as the S&P/ASX 200 reflected broad sector movement, with materials, financials, and resource stocks shaping overall market activity.
Four D Medical (ASX:4DX) Shares Active, All Ordinaries Context
January 20, 2026 05:05 PM AEDT| By SamObjective overview of Four D Medical Limited highlighting healthcare technology operations, imaging solutions, distribution approach, and market context within the Australian equity landscape.
Healthcare Equipment Representation Across ASX 200 and ASX 100 Indices
January 20, 2026 04:27 PM AEDT| By SamHealthcare technology companies within the ASX 200 operate under regulated frameworks that integrate engineering, clinical collaboration, and global healthcare systems.
Nova Eye Medical (ASX:EYE) Shares Track ASX All Ordinaries
January 20, 2026 04:09 PM AEDT| By SamA factual look at Nova Eye Medical Limited, highlighting sector role, ophthalmic focus, and how broader market measures like the All Ordinaries provide contextual insight.
Illuccix Regulatory Progress Positions Telix Pharmaceuticals Across ASX 200 Landscape
January 20, 2026 02:09 PM AEDT| By SamTelix Pharmaceuticals records regulatory acceptance progress for Illuccix in China, reinforcing its international healthcare engagement within major ASX indices.
Digital Health Services Spotlight Cogstate Across All Ordinaries Index
January 20, 2026 12:27 PM AEDT| By SamCogstate operates within digital healthcare technology, delivering cognitive assessment platforms and maintaining participation within the All Ordinaries index of the Australian share market.
Advertise your brand on Kalkine Media